Comparative Safety and Tolerability of Clopidogrel and AspirinResults from CAPRIE

被引：0
作者：
Laurence A. Harker
Jean-Pierre Boissel
Alison J. Pilgrim
Michael Gent
机构：
[1] Emory University School of Medicine,Division of Hematology and Oncology, Department of Medicine
[2] Service de Pharmacologie Clinique,Hamilton Civic Hospitals Research Centre
[3] Sanofi Recherche,Hamilton Civic Hospitals Research Centre
[4] McMaster University,undefined
[5] Clinical Trials Methodology Group,undefined
来源：
Drug Safety | 1999年 / 21卷
关键词：
Aspirin; Adis International Limited; Clopidogrel; Ticlopidine; Thrombotic Thrombocytopenic Purpura;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：325 / 335
页数：10
相关论文
共 31 条
[1]  
Murray C.J.L.(1997)Global mortality, disability and the contribution of risk factors: global burden of disease study Lancet 349 1436-42
[2]  
Lopez A.D.(1994)Collaborative overview of randomised trials of antiplatelet therapy — I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 81-106
[3]  
Solomon D.H.(1994)Antithrombotic therapies for stroke prevention Curr Opin Neurol 7 48-53
[4]  
Hart R.G.(1990)The effect of warfarin on mortality and reinfarction after myocardial infarction N Engl J Med 323 147-52
[5]  
Smith P.(1994)Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction Lancet 343 499-503
[6]  
Arnesen H.(1982)Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction Lancet I 64-8
[7]  
Holme I.(1996)A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1329-39
[8]  
Green D.(1997)CAPRIE trial [letter] Lancet 349 354-5
[9]  
Young N.S.(1995)Aplastic anaemia Lancet 346 228-32
[10]  
Hass K.W.(1989)A randomised trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients N Engl J Med 321 501-7
1234